mRNA– tag –
-
ARPA-H Invests $125M in On-Demand RNA Medicine Manufacturing; ArsenalBio Pivots to In Vivo CAR T Cell Therapies for Solid Tumors
The Pharma Letter USA Overview ARPA-H has committed $125 million to five teams developing on-demand manufacturing capabilities for RNA medicines, a strategic investment to enhance rapid pharmaceutical response to future public health cri... -
Journal of the American Chemical Society Reports Photochemistry-Based Lipid Library Significantly Improves mRNA-LNP Delivery In Vivo
Journal of the American Chemical Society USA Overview A study in the Journal of the American Chemical Society reports the development of a photochemistry-based ionizable lipid library (PILL) platform for rapid discovery of ionizable lipi... -
NUS Medicine and Tianjin Medical University Develop Bioinspired LNP Gene Therapy, Achieving Over 20% Cholesterol Reduction by Targeting PCSK9 Gene in Liver
Technology Networks Singapore/China Overview Researchers from NUS Medicine and Tianjin Medical University General Hospital have developed a bioinspired lipid nanoparticle (LNP) capable of delivering gene-editing machinery to the liver. T... -
Review Highlights PLGA and LNP Nanomaterials as Key to Inducing Transplantation Tolerance, Improving Targeted Delivery and Sustained Release
Frontiers in Immunology International Overview A review in *Frontiers in Immunology* outlines advances in nanomaterial-based delivery systems for inducing transplantation tolerance. Polylactic-co-glycolic acid (PLGA) polymeric nanopartic... -
Nagoya University & FUJIFILM Develop FL0445-LNP, Enhancing Circular RNA Activity Tenfold with Negligible Inflammation for Longer-Lasting mRNA Treatments
Clinical Lab Japan Overview Researchers at Nagoya University and FUJIFILM Corporation have developed a new lipid nanoparticle (LNP), FL0445-LNP, for delivering circular RNA (cirRNA) into cells. This system improves mRNA activity tenfold ... -
MSD-Moderna Personalized mRNA Neoantigen Combination Adjuvant Therapy Reports Positive Phase III Results in Melanoma
European Pharmaceutical Review USA Overview MSD (Merck) and Moderna's personalized mRNA neoantigen combination adjuvant therapy has announced positive results from its Phase III clinical trial in high-risk melanoma patients. The data sug... -
Broad Institute Achieves Long-Term Brain Organoid Longevity and Streamlines Prime Editing with AI
Broad Institute USA Overview The Broad Institute announced a significant milestone on August 20, 2026, where an AI model streamlined the prime editing process and enabled the long-term longevity of brain organoids. The institute actively... -
Comprehensive Review of CRISPR Gene Therapy: Potential Applications and Challenges for Sickle Cell Disease and Beta-Thalassemia
International Journal of Basic & Clinical Pharmacology Global Overview A comprehensive review covered the discovery, mechanism, therapeutic applications, and current limitations of CRISPR-Cas9, a revolutionary genome editing technology t... -
CRISPR Frontiers 2026: Innovations in DSB-Independent Editing and Delivery Systems Boost Genome Editing Precision and Stability
Addgene Blog USA Overview The 'Genome Engineering: CRISPR Frontiers 2026' conference reported significant evolution in CRISPR technology towards precise, double-strand break (DSB)-independent editing. Researchers are focusing on enhancin... -
AGC Biologics Secures Multi-Million Dollar Commercial Manufacturing Deal for Yokohama Facility Ahead of 2027 Opening
히트뉴스 (HITNews) South Korea Overview AGC Biologics has signed a multi-year commercial manufacturing contract with an undisclosed global biopharmaceutical company for its new Yokohama facility, reserving approximately half of its mamma...
